From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
In its latest, proposed incarnation, Ruse Treatment representatives outlined plans for a high-end care destination comparable ...
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer to cut drug prices and sell medications on TrumpRx, a direct-to-consumer federal ...
In September 2025, the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed ...
Scientists are exploring how RNA might have jump-started life four billion years ago and how it's now advancing drug ...
Today (September 11), the Lasker Foundation announced this year’s award winners. Jesús (Tito) González, an ion channel biologist formerly at Vertex Pharmaceuticals, Paul Negulescu, a cell biologist at ...
By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But ...
Earlier this week, the FDA held a public meeting to discuss its broader efforts to support U.S. pharmaceutical manufacturing, ...
These criteria ensure that the drug offers a genuine therapeutic difference, a requirement for its effectiveness against evolving AMR. Considering it can take 15 years and cost over $1 billion to ...
SAN MATEO, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback